New facility to support existing drug development center

Written by Lisa Parks, Future Science Group
Drug development General interest News
Biopharmaceuticals side view, illustrating the development of drugs using genetic engineering - drug development, cybernetic tone, Monochromatic Color Scheme

Drug development research center will conduct drug metabolism studies, develop new compounds and carry out clinical tests for drugs.

 

Agilent Technologies Inc. (CA, USA), has recently announced a collaboration with Seoul National University (SNU; Seoul, South Korea) for a new research center. The new center will support the existing College of Pharmacy’s new drug development center, a six-story multi-purpose research center for drug development. The new collaboration aims to conduct drug metabolism studies, develop new compounds, assess remedial effects and toxicity, evaluate pharmacokinetics and carry out clinical tests for drugs.

Bong-Jin Lee, Dean of the College, commented, “The College of Pharmacy at SNU has a long tradition of driving innovation. We have been leading Korea’s pharmaceutical industry through the strategic use of technology and driving the development of new drugs. As we prepare students for the future, we will push the frontiers of drug development by expanding our research facilities, producing outstanding research, and leading the development of technology. We are pleased to collaborate with Agilent, as our scientists and researchers require the latest, most sophisticated instruments for their work.”

As part of the agreement, Agilent will provide the College of Pharmacy with bioanalytical instruments and their expertise in drug testing. The newly established research center will be used by Agilent as its reference site for drug development.

Rod Minett, Agilent’s general manager of Life Sciences, South Korea and South Asia-Pacific region, stated, “One of the megatrends fueling life science research is the aging population. Through continual research, trials and developments, we believe that newer, more effective drugs can be developed. As such, Agilent is pleased to support SNU College of Pharmacy’s drive to create better drugs for a safer and healthier population.”

Source: Agilent Technologies collaborates With Seoul National University on new research center.